Norfolk Recovery Partnership (NRP), the UK organization that provides advice and treatment for adults with drug and alcohol problems across Norfolk, England, has completed a successful trial of Intelligent Fingerprinting’s revolutionary fingerprint-based drug screening system. The NRP drug rehabilitation service, which is run by a partnership of Norfolk and Suffolk NHS Foundation Trust, The Matthew Project and The Rehabilitation of Addicted Prisoners Trust, operates from seven sites across Norfolk, as well as providing advice and treatment services in three local prisons.
The Intelligent Fingerprinting solution is the world’s first portable fingerprint-based drug screening system. Its non-invasive approach – which detects drug use by analyzing chemicals, known as metabolites, contained in the minute traces of sweat found in a fingerprint sample – makes it ideal to support rehabilitation services across both clinical and community-based sites. The system is particularly dignified for service users, requiring a single fingerprint sample that takes just five seconds to collect and provides simultaneous results in under 10 minutes for amphetamines, cannabis, cocaine and opiates.
During the trial, NRP found that fingerprint-based drug screening was particularly easy to use, with none of the hygiene or administrative issues typically associated with traditional drug screening methods that use saliva or urine. According to Christopher Strivens, Deputy Service Manager for NRP: “With Intelligent Fingerprinting there’s now a drug screening approach that is both non-invasive and easy to use. Fingerprint-based screening certainly looks like it will prove a valuable technology for use by drug rehabilitation services.”
Dr. Paul Yates, Intelligent Fingerprinting’s Business Development Director, added: “Norfolk Recovery Partnership has seen the benefits that our portable drug screening system can bring to drug rehabilitation services. Initial trials have shown how the Intelligent Fingerprinting system can support NRP’s requirement for a more flexible drug screening approach that will enable them to extend screening across their activities. Thanks to the portability of our system, we can also help NRP save time by enabling on location drug screening results. Critically, our technology also went through NRP’s own governance and ethics processes, and its positive acceptance by both staff and service users suggests that there’s a clear role for a screening approach that treats drug rehabilitation service users with much more dignity.”
The Intelligent Fingerprinting Drug Screening System consists of a novel, four-panel fingerprint drug test cartridge and the portable Intelligent Fingerprinting Reader 1000.
Watch our video to learn more about how non-invasive drug screening works, and how it has the potential to revolutionize drug screening in drug rehabilitation organizations:
For forensic use only.
For media information contact Cheryl Billson at Comma
Email: email@example.com Tel: +44 (0)7791 720460
Notes to Editors:
About Norfolk Recovery Partnership
Norfolk Recovery Partnership (NRP) is run by a partnership of Norfolk and Suffolk NHS Foundation Trust, The Matthew Project and The Rehabilitation of Addicted Prisoners Trust and provides advice and treatment for adults with drug and alcohol problems across Norfolk, England.
NRP’s friendly, committed and enthusiastic staff offer a range of services from expert advice through to full confidential assessment; leading on to a comprehensive range of treatments to meet service user needs.
Anyone aged over 18 can drop in to one of its five bases across Norfolk and talk to a member of staff and can be assessed for treatment straight away.
NRP bases offer needle exchange services.
NRP also operates in prisons across Norfolk
About Intelligent Fingerprinting
Intelligent Fingerprinting’s unique fingerprint-based portable Drug Screening System is set to revolutionize the way drug screening is carried out across a range of sectors. The distinctive Intelligent Fingerprinting technology, which works by analyzing the sweat from a fingerprint sample, enables non-invasive, cost-effective screening for multiple drug groups in less than 10 minutes.
Intelligent Fingerprinting has attracted worldwide interest in its technology from a wide range of drug-screening markets including the criminal justice arena, drug rehabilitation centers, prisons and occupational health services. The technique has potential for many other uses including healthcare diagnostics and homeland security applications.
The company’s ground-breaking technology detects drug use by analyzing chemicals, known as metabolites, contained in the minute traces of sweat found in a fingerprint. (Metabolites are chemicals produced by the body as a result of normal metabolic processes.) The Intelligent Fingerprinting Drug Screening System looks for the presence of specific drugs or drug metabolites in the test subject’s fingerprint sweat sample and, if detected, identifies which drugs have been consumed.
Since 2012 Intelligent Fingerprinting has raised £11.23m in funding from a consortium of private UK and US-based investors, as well as government funding for pilot studies within the UK’s National Health Service and coroners’ services.
Founded in 2007, Intelligent Fingerprinting is a spin-out company from the University of East Anglia (UEA). The company is based in Cambridge, England and currently employs 30 people.
Follow us on Twitter @iFingerprinting